Patents by Inventor Ruijie Liu

Ruijie Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240138408
    Abstract: A composition and use thereof. The composition comprises an active component a and an active component b; the active component a is a compound as shown in general formula A; and the active component b is at least one of compounds which have insecticidal, acaricidal or bactericidal activity and are different from the compound as shown in general formula A. The composition has the advantages of synergistic effect and expanding prevention and treatment spectrum, and can be used for preventing and treating various pests, particularly mite damage, and plant diseases caused by various fungi, bacteria, nematodes and viruses.
    Type: Application
    Filed: January 28, 2022
    Publication date: May 2, 2024
    Inventors: Ning LI, Yingshuai LIU, Yingrui CUI, Xiangwei LIU, Ruibin LIU, Yunxiao SUN, Shien FAN, Yu CHEN, Baohong LIU, Jiajie NIU, Jie GAO, Ruijie FENG, Qinan HAN, Bin LI
  • Publication number: 20240146375
    Abstract: Embodiments of this application provide a communication method and a related device. The method includes: A terminal device obtains a plurality of power offset values corresponding to one reference signal resource, determines a plurality of pieces of channel state information CSI based on the plurality of offset values, and sends some or all of the plurality of pieces of CSI to a network device. The network device may flexibly adjust data transmit power based on the plurality of power offset values and the plurality of pieces of corresponding CSI, and perform appropriate link adaptation adjustment.
    Type: Application
    Filed: January 5, 2024
    Publication date: May 2, 2024
    Inventors: Shengyu Li, Di Zhang, Kunpeng Liu, Yang Ding, Ruijie Li
  • Publication number: 20210386087
    Abstract: The present invention provides an application of tilapia oil or fractionated product thereof, which belongs to the technical field of food technology. The applications involve in swine feed, fat for replacing breast milk, or dairy products. The present invention found that palmitic acid, oleic acid and linoleic acid in tilapia oil, and more than 65% of palmitic acid is distributed in sn-2 position, the highest content of triglyceride OPL, can be used as fat additives in swine feed or formula milk powder use oil. Therefore, adding tilapia oil to swine feed or formula milk powder is beneficial to the absorption of fatty acids and calcium, and can improve the absorption and utilization of energy.
    Type: Application
    Filed: March 29, 2021
    Publication date: December 16, 2021
    Inventors: Xiaosan WANG, Xinyi CHENG, Zhuangzhuang YANG, Cong JIANG, Jianhua HUANG, Ruijie LIU, Ming CHANG
  • Patent number: 10669266
    Abstract: Compounds that are selective inhibitors of Smad3 activation are disclosed. The compounds have the following structure: in which Z is an oxadiazole. The compounds disclosed are useful in treatment of fibrotic disease, particularly renal fibrosis, and similar diseases associated with the dysregulation of the HIPK2/Smad3 signaling pathway.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: June 2, 2020
    Assignees: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, UNIVERSITY OF KANSAS
    Inventors: John Cijiang He, Ruijie Liu, Bhaskar Das, Wenzhen Xiao, Zhengzhe Li, Kyung Lee
  • Publication number: 20190352292
    Abstract: Compounds that are selective inhibitors of Smad3 activation are disclosed. The compounds have the following structure: in which Z is an oxadiazole. The compounds disclosed are useful in treatment of fibrotic disease, particularly renal fibrosis, and similar diseases associated with the dysregulation of the HIPK2/Smad3 signaling pathway.
    Type: Application
    Filed: January 5, 2018
    Publication date: November 21, 2019
    Applicants: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, UNIVERSITY OF KANSAS
    Inventors: John Cijiang HE, Ruijie LIU, Bhaskar DAS, Wenzhen XIAO, Zhengzhe LI, Kyung LEE
  • Publication number: 20170313667
    Abstract: The present invention provides the use of ATG in the preparation of a reagent for adjusting the activity of PP2A; and the use of ATG in increasing the activity of PP2A in 293T cells. The present invention also provides the use of the arctigenin in the preparation of the medicine for reducing the proteinuria of the diabetic mice. The present invention also provides the use of the arctigenin in the preparation of the reagent for inhibiting the expression of the NOX4 gene. The present invention also provides analogues of arctigenin and application thereof. The present invention provides a novel use of ATG for modulating PP2A activity, and ATG can also significantly reduce proteinuria in diabetic mice. At the same time, arctigenin could significantly inhibit the expression of NOX4 in STZ-eNOS?/? mice glomeruli. The ATG analogues of the present invention are more effective than the native ATG.
    Type: Application
    Filed: March 17, 2017
    Publication date: November 2, 2017
    Applicant: Longhua Hospital Shanghai University of Traditional Chinese Medicine
    Inventors: Yifei Zhong, John Cijiang He, Bhaskar Das, Ruijie Liu, Honggang Gu
  • Publication number: 20020194929
    Abstract: This invention is a method for determining the compressive strength of cores obtained from concrete or similar materials by applying the load on 4 lines on the core cylindrical surface through a specially designed but very simple apparatus. The four loading lines are uniformly distributed on the circumstance of the test section of the core through using the apparatus so that the core is compressed in two diametrical directions—dual-dual directions orthogonal to each other. The stresses in the test section of cores are in three dimensional compression state and thus the test is of compressive nature. This invention avoids the trimming, capping, and curing operations which the conventional core test has to follow. Moreover, some factors that may result in the reduction in the reliability and the practical benefit of the core test can be greatly restrained or removed.
    Type: Application
    Filed: June 22, 2001
    Publication date: December 26, 2002
    Inventors: Ruijie Liu, Maoxin Li